BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement

Lung Fortress is a new potent, derivative natural supplement to support pulmonary health amid rising concerns for seasonal increases in respiratory problems

LAS VEGAS, NV / ACCESSWIRE / October 10, 2023 / BioAdaptives, Inc. (OTC PINK:BDPT), a leading formulator and distributor of innovative, all-natural dietary supplements, today announces the launch of Lung Fortress, a robust, all-natural supplement formula designed to foster pulmonary health, in response to the anticipated seasonal increases in respiratory illnesses.

Lung Fortress is a more potent, advanced derivative of the popular BioAdaptives product, PrimiLungs, first marketed four years ago. Lung Fortress is designed to promote lung health by increasing resilience to stressful threats such as airborne chemicals and particles, such as pollution, and to aid recovery from various inflammatory conditions. The ingredients are known to have anti-inflammatory and antiviral properties that support the immune system.

Health authorities are highlighting the increased risk of respiratory illnesses, including complications from viruses like influenza, respiratory syncytial virus (RSV), and COVID-19 during the coming winter months. Viral illnesses can be difficult to combat, and a healthy immune system remains the most important line of defense against harmful threats. Lung Fortress is specifically formulated to provide immune support and to strengthen the lungs under stress.

Edward Jacobs, M.D., BioAdaptives CEO, stated, "We are delighted to announce the launch of Lung Fortess in anticipation of the expected rise in seasonal respiratory illnesses. Lung Fortress is a more potent, advanced derivative of PrimiLungs, our popular lung supplement formula that has received favorable reports from many consumers, especially Seniors, since its market debut four years ago."

About BioAdaptives, Inc.

BioAdaptives, Inc. develops and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress; endurance; recovery from injury, illness, and exercise; and anti-aging properties. The Company's current dietary supplement formulations are carefully selected from the best sources around the world and utilize proprietary methods of enhancing the bioavailability of nutrients. BioAdaptives' current product line includes PrimiLungs, PluriPain, SleepEZ, MindnMemory and Cell Rejuven for humans. The Company's products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as providing improvements in appearance. BioAdaptives' wholly owned subsidiary, LiveStock Impact, Inc markets Canine Regen All In One, Equine All In One and Equine All In One Plus for dogs and horses. LiveStock Impact, Inc is also positioned to develop and market botanical drugs.